Successful treatment of pediatric post-liver transplant Kaposi's sarcoma with paclitaxel

Simple item page
dc.contributor.authorSen, Hilal Susam
dc.contributor.authorAtes, Belen Terlemez
dc.contributor.authorYilmazbas, Pinar
dc.contributor.authorOcak, Suheyla
dc.contributor.authorKirimlioglu, Hale
dc.contributor.authorGokce, Selim
dc.contributor.authorAcarli, Koray
dc.date.accessioned2023-02-21T12:35:37Z
dc.date.available2023-02-21T12:35:37Z
dc.date.issued2020-01-01
dc.description.abstractBackground. Kaposi's sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients. Unlike adult recipients, KS in pediatric organ transplantation is quite rare. Treatment is usually withdrawal of immunosuppression
dc.description.abstractnon-responders often receive chemotherapy. Case. We have reported a child with post-liver transplant visceral KS which has progressed despite withdrawal of immunosuppressive therapy, who has been treated with Paclitaxel for three weeks. KS has regressed completely after four cycles of Paclitaxel. Conclusion. Paclitaxel should be considered as an effective first line treatment option for patients with post-transplant KS.
dc.description.issue5
dc.description.issueSEP-OCT
dc.description.pages858-862
dc.description.volume62
dc.identifier.doi10.24953/turkjped.2020.05.020
dc.identifier.urihttps://hdl.handle.net/11443/1965
dc.identifier.urihttp://dx.doi.org/10.24953/turkjped.2020.05.020
dc.identifier.wosWOS:000582494600019
dc.publisherTURKISH J PEDIATRICS
dc.relation.ispartofTURKISH JOURNAL OF PEDIATRICS
dc.subjectKaposi's sarcoma
dc.subjectchildren
dc.subjectpaclitaxel
dc.titleSuccessful treatment of pediatric post-liver transplant Kaposi's sarcoma with paclitaxel
dc.typeArticle

Files

Collections

WOS